Transaction deepens insights into Sec61 selectivity for targeted protein degradation, supporting accelerated development of Enodia’s novel small-molecule inhibitors “Kezar has made significant early ...
Proteins in cellular membranes contain one or more segments known as transmembrane domains (TMDs). Insertion of these TMDs into the membrane is a key step during the production of new membrane ...
In the world of protein degradation, sometimes a spanner in the works isn’t an inconvenience but the desired result. Paris-based Enodia Therapeutics has launched out of France’s Pasteur Institute and ...
PARIS & SOUTH SAN FRANCISCO, Calif. Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, and Kezar Life ...
Transaction deepens insights into Sec61 selectivity for targeted protein degradation, supporting accelerated development of Enodia’s novel small-molecule inhibitors Enodia Therapeutics, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results